BARTLETT & CO. WEALTH MANAGEMENT LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 2010186
CINCINNATI, OH
Position in REGN
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$226,345
-$53,350 QoQ
Shares Held
363
+0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,017
of 1,328 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 5%
Shared 0%
None 95%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARTLETT & CO. WEALTH MANAGEMENT LLC holds $1,629,105 across 20 Biotechnology names. REGN ranks #4 (13.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
11,100 | $605,394 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
4,144 | $324,350 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
575 | $285,619 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
363 | $226,345 | |
| 5 | INCY |
Incyte Corp
|
363 | $41,149 | |
| 6 | DNLI |
Denali Therapeutics Inc.
|
1,500 | $38,580 | |
| 7 | CADL |
Candel Therapeutics, Inc.
|
3,520 | $36,256 | |
| 8 | GUTS |
Fractyl Health, Inc.
|
25,000 | $19,850 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $226,345 | 363 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $279,695 | 362 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $278,645 | 361 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $202,979 | 361 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $182,175 | 347 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $218,175 | 344 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $245,041 | 344 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $361,626 | 344 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $361,554 | 344 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $333,021 | 346 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $302,131 | 344 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $283,098 | 344 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $247,177 | 344 | Shares | Sole | 2024-02-14 | |
| 2023-03-31 | $282,654 | 344 | Shares | Sole | 2024-02-14 | |
| 2022-12-31 | $248,192 | 344 | Shares | Sole | 2024-02-14 | |
| 2022-09-30 | $236,971 | 344 | Shares | Sole | 2024-02-14 | |
| 2022-06-30 | $203,348 | 344 | Shares | Sole | 2024-02-14 | |
| 2022-03-31 | $240,256 | 344 | Shares | Sole | 2024-02-14 | |
| 2021-12-31 | $217,242 | 344 | Shares | Sole | 2024-02-14 | |
| 2021-09-30 | $208,181 | 344 | Shares | Sole | 2024-02-14 | |
| 2021-06-30 | $197,164 | 353 | Shares | Sole | 2024-02-14 | |
| 2021-03-31 | $167,018 | 353 | Shares | Sole | 2024-02-14 | |
| 2020-12-31 | $170,537 | 353 | Shares | Sole | 2024-02-13 | |
| 2020-09-30 | $192,564 | 344 | Shares | Sole | 2024-02-13 | |
| 2020-06-30 | $214,535 | 344 | Shares | Sole | 2024-02-13 | |
| 2020-03-31 | $102,052 | 209 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||